Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines.
about
Use of metformin in the setting of mild-to-moderate renal insufficiencyBenefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewContraindications to the use of metforminMetformin: Current knowledgeAssociation of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy.Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.Metformin in peritoneal dialysis: a pilot experienceMetformin's contraindications should be contraindicated.Laboratory monitoring of drugs at initiation of therapy in ambulatory care.Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.Metformin-associated lactic acidosis: predisposing factors and outcomeMetformin in patients with type 2 diabetes and kidney disease: a systematic review.Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese miceNoninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?Lactic Acidosis in Diabetic Population: Is Metformin Implicated? Results of a Matched Case-Control Study Performed on the Type 2 Diabetes Population of Grenoble Hospital UniversityA randomized trial of electronic clinical reminders to improve medication laboratory monitoring.Electronic medical record prompts for lab orders in patients initiating statins.Type 2 diabetes mellitus and heart failure.Update on diabetes mellitus: prevention, treatment, and association with oral diseases.Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality.Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group study.Metformin therapy and clinical uses.Lactic acidosis and the relationship with metformin usage: Case reports.Low agreement between the modified diet and renal disease formula and the Cockcroft-Gault formula for assessing chronic kidney disease in cognitively impaired elderly outpatients.Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.Unleash metformin: reconsideration of the contraindication in patients with renal impairment.Lactate Levels with Chronic Metformin Use: A Narrative Review.Metformin associated lactic acidosis (MALA): clinical profiling and management.Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.Cardiovascular Drugs and Metformin Drug Dosage According to Renal Function in Non-Institutionalized Elderly Patients.Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney functionMetformin's contraindications: needed for now.Lactic acidemia associated with metformin.Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media.Metformin--current restrictions should be alleviated.Do risk factors for lactic acidosis influence dosing of metformin?Trends in and patterns of obesity reduction medication use in an insured cohort.
P2860
Q22241290-7ACB3AB4-9A16-41B0-AA41-059A899BF266Q22242077-CCB6C305-A795-439C-849D-4CEE87510B74Q22242091-75DD66B5-9BB6-42BB-8853-DA1DB33419A5Q26853666-45651C32-12AC-4DB5-AFF7-232BE831734AQ33556757-3C29F802-E6E1-485F-94CF-705138A493D6Q33705903-A4E9E420-61B9-45D6-9E71-0B2AD4D4121AQ33837650-CECB517A-BE3C-4F15-A0EC-949CE5ECFA72Q33920606-21F5C0AC-E780-466B-BD54-B10A863CB5FBQ34724676-31F499DA-2B31-42D8-9E46-7BE56C781A40Q35186548-2E3019D2-DCA8-4AFC-89A2-28997620094FQ35260863-995F1572-B261-429B-9272-EF3CFAC91991Q35533239-F6BCC7AB-7350-4FBE-9FEA-0EAC5AF32453Q35981002-C3FC98B6-43DA-4260-83E4-60C2FB6E1C74Q36003873-3F6240E2-0296-4FFA-BFCA-86D05167E7FAQ36531654-AE7B341A-5865-4501-900E-65D121F565E2Q36680984-809B5D9D-9005-4DF4-A4BC-A2579A5BD19CQ36741423-9051A8A5-CF46-4CE5-9F7D-93DD2EE2CB4FQ36782937-9CCEDAF5-4A9A-4B48-A606-160B2FBC5D2AQ37069176-0BA0A2C3-6BBC-4209-BD4D-88F6F626405CQ37095581-535F051C-F8BE-46EA-A4D9-635F514C310CQ37102216-9C15F15E-F9F3-4C0A-94EC-91263B8240E2Q37196371-DD6F096B-963F-4A81-99E9-D402DC117F05Q37262966-16B02660-2D5E-4A59-B6CC-8D9B001EEA92Q37432861-255613F9-59F3-4109-89EC-789FC9227D14Q37810410-A6A65F33-CE87-43AF-8445-00FC7BE75056Q37982112-8B540C92-9EF6-4D74-ADB5-A237C0186F3BQ38086611-91102D8F-CF19-4DBC-A47B-0E0DF898F082Q38095393-B86D6E1D-E207-4FFF-AC90-3D50B11A3811Q38164656-946FF04E-19C5-4B98-9861-8249FAC4B3B4Q38637898-3BE9F907-74D3-4593-81E5-1F73A02BDA6CQ38708321-1D67EE57-9CDF-4154-B3FE-857759611ACBQ39832428-5A920C79-4565-489F-8CA6-764BBD0C440DQ40907977-60DD2819-90EB-403A-8671-7BFD6ECCF4CCQ42281416-0A8EEEFB-36D4-4294-B4BD-A23C2FAD1861Q42939042-E60E966D-DA6F-433E-8B2B-846167857DBBQ44263669-12AAA67C-65FA-4B64-BCAF-4E4C417AAF92Q45037776-72726D19-F246-4D55-8DF6-42E0D79F090AQ45058826-624D8B4E-3586-402D-ACAD-E6D2B76594C5Q45105247-C82D7074-0EFA-4F5D-A976-540308DB354AQ45981884-02A60E7D-24F2-4DAD-8496-A003AF5B8874
P2860
Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Contraindications to metformin ...... nce to prescribing guidelines.
@en
Contraindications to metformin ...... nce to prescribing guidelines.
@nl
type
label
Contraindications to metformin ...... nce to prescribing guidelines.
@en
Contraindications to metformin ...... nce to prescribing guidelines.
@nl
prefLabel
Contraindications to metformin ...... nce to prescribing guidelines.
@en
Contraindications to metformin ...... nce to prescribing guidelines.
@nl
P2093
P2860
P1433
P1476
Contraindications to metformin ...... nce to prescribing guidelines.
@en
P2093
A D Morris
A M Emslie-Smith
DARTS/MEMO Collaboration
P2860
P304
P356
10.1046/J.1464-5491.2001.00509.X
P577
2001-06-01T00:00:00Z